Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2

Introduction

Chimeric antigen receptor (CAR) T-cell therapy is a treatment option for patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) after first-line treatment and who are ineligible for autologous hematopoietic cell…